anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

135,301-135,360 of 319,975

filter-aware
01
Slide 1
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Situation & Context1 hit
02
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Situation & Context1 hit
03
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Situation & Context1 hit
04
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Situation & Context1 hit
05
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Situation & Context1 hit
06
The chart highlights the significant outperformance of Pershing Square relative to the S&P 500 index over the specified period.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
07
The slide uses a split-table format to contrast positive and negative performance contributors.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
08
The slide uses a table to demonstrate historical performance attribution.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
09
The slide includes a footnote clarifying the relationship between core funds and co-investment vehicles.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
10
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
11
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
12
This slide serves as a company profile for an activist investor presentation.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
13
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
14
Multiple holdings (Pershing Square portfolio)Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
15
The chart highlights Mondelez's underperformance relative to peers, with Mondelez shown in red.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
61
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
62
Herbalife, Ltd. (HLF)Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
63
The slide highlights the specific criteria (30 participants, 3 levels) for criminal liability in China.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor 1 hit
01
Slide 1
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · Pershing Square Holdings
Press release Activist investor 1 hit
01
Slide 1
Pershing Square Capital Management, L.P. logo and name present.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Setup1 hit
02
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Setup1 hit
03
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Setup1 hit
04
This slide serves as a company profile/introductory slide for an activist investor deck.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Setup1 hit
05
The slide outlines the core pillars of the Valeant business model, including M&A, leverage, and decentralized structure.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
06
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
07
The chart uses callout boxes to link specific dates and events to the share price trajectory.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
08
The slide uses a line chart with callout boxes to correlate specific news events with stock price volatility.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
09
Uses a timeline-annotated line chart to frame market volatility as a series of events to be addressed.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Complication1 hit
10
The slide uses a simple list format to explain the value proposition of specialty pharmacies followed by a logo grid of industry participants.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
11
This slide is part of a series exposing the Valeant-Philidor relationship.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
12
The slide uses a value-chain diagram to illustrate the structural change in the supply chain.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
13
The slide highlights the contradiction between Valeant's accounting consolidation of Philidor and their public claim of non-control.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
14
The slide uses color-coding to distinguish between Valeant-related events and Philidor-related events, illustrating the opaque nature of their business relationship.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
15
The timeline uses color-coding to distinguish between entities involved in the dispute.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
16
The slide uses a direct quote from a legal complaint to undermine the credibility of the subject.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
17
Image file at /tmp/legacy-images/4934d687cb38/slides/017.jpg does not exist on disk; unable to inspect contents.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
18
The slide uses color-coded boxes to distinguish between entities involved in the timeline events.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
19
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
20
The table serves as a precedent for regulatory risk and financial impact in the pharmaceutical industry.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
21
The slide uses a 'villain' framing by contrasting the high penalties of established peers against the absence of the target company (Valeant).Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Preempt Rebuttal1 hit
22
Uses a direct quote from a U.S. Attorney to establish credibility and frame the villain.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
23
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
24
The slide uses a bulleted list to structure the case study details, focusing on legal and ethical misconduct.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
25
The slide uses a quote to contrast the company's public admission of wrongdoing with their internal dismissal of business risk.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
26
This slide serves to preemptively address potential accusations of complicity or prior knowledge regarding Valeant's controversial specialty pharmacy practices.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
27
The slide uses a structured list format to contrast Valeant's stated answers against the underlying unresolved questions.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor 1 hit
28
The slide uses a chronological list to frame expectations for the company's future.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
29
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
30
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
31
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
32
The slide uses a 'floor' valuation approach to argue for the stock's undervaluation.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
33
The slide uses a DCF-style valuation bridge to demonstrate upside potential from the current share price of $111.50.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
34
The slide uses a DCF-style valuation bridge to calculate potential returns based on 2020 EPS projections.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
35
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
36
This slide serves as a historical precedent for corporate fraud and due diligence failure.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
37
Uses historical precedent to frame current investment thesis.Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
38
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
39
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Activist deck Activist investor Beat · Resolution1 hit
01
Slide 1
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · Pershing Square Holdings
Press release Activist investor Beat · Attention1 hit
01
Slide 1
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · Pershing Square Holdings
Press release Activist investor Beat · Attention1 hit